Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?

Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, Brogyuk N, Bunganic B, Seifert B, Dusek L, Zavoral M.

World J Gastroenterol. 2016 Sep 28;22(36):8103-11. doi: 10.3748/wjg.v22.i36.8103. Review.

2.

Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.

Khankari NK, Shu XO, Wen W, Kraft P, Lindström S, Peters U, Schildkraut J, Schumacher F, Bofetta P, Risch A, Bickeböller H, Amos CI, Easton D, Eeles RA, Gruber SB, Haiman CA, Hunter DJ, Chanock SJ, Pierce BL, Zheng W; Colorectal Transdisciplinary Study (CORECT).; Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE).; Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE).; Transdisciplinary Research in Cancer of the Lung (TRICL)..

PLoS Med. 2016 Sep 6;13(9):e1002118. doi: 10.1371/journal.pmed.1002118.

3.

3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.

Cho SH, Ko JJ, Kim JO, Jeon YJ, Yoo JK, Oh J, Oh D, Kim JW, Kim NK.

PLoS One. 2015 Jul 6;10(7):e0131125. doi: 10.1371/journal.pone.0131125.

4.

Mendelian randomization study of height and risk of colorectal cancer.

Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Esko T, Wood AR, Yang J, Vedantam S, Gustafsson S, Pers TH; GIANT Consortium., Baron JA, Bezieau S, Küry S, Ogino S, Berndt SI, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lemire M, Lindor NM, Seminara D, Song M, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Schoen RE, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT.

Int J Epidemiol. 2015 Apr;44(2):662-72. doi: 10.1093/ije/dyv082.

5.

Should screening for colorectal neoplasm be recommended in patients at high risk for coronary heart disease: a cross-sectional study.

Basyigit S, Ozkan S, Uzman M, Ertugrul DT, Kefeli A, Aktas B, Yeniova AO, Asilturk Z, Nazligul Y, Simsek H, Simsek G, Ayturk M, Yavuz B.

Medicine (Baltimore). 2015 May;94(20):e793. doi: 10.1097/MD.0000000000000793.

6.

Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case-control study.

Díaz-Algorri Y, Lozada ME, López SM, Bertrán-Rodríguez CE, González-Hernández CM, González D, Pérez-Cardona CM, Hernández J, Pedrosa C, Toro DH, González-Pons M, Cruz-Correa M.

J Diabetes Complications. 2015 May-Jun;29(4):502-7. doi: 10.1016/j.jdiacomp.2015.01.010.

7.

Diabetes Mellitus and Colorectal Neoplasia.

Acevedo A, Diaz Y, Perez CM, Garau M, Baron J, Cruz-Correa M.

J Cancer Ther. 2012 Nov 1;3(6A):859-865.

8.

Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study.

Zhang C, Yu L, Xu T, Hao Y, Zhang X, Liu Z, Xiao Y, Wang X, Zeng Q.

PLoS One. 2013;8(3):e59796. doi: 10.1371/journal.pone.0059796.

9.

Fasting blood sugar and serum triglyceride as the risk factors of colorectal adenoma in korean population receiving screening colonoscopy.

Pyo JH, Kim ES, Chun HJ, Keum B, Jeen YT, Lee HS, Kim CD, Ryu HS, Kim YH, Lee JE.

Clin Nutr Res. 2013 Jan;2(1):34-41. doi: 10.7762/cnr.2013.2.1.34.

10.

Obesity and risk of colorectal cancer: a systematic review of prospective studies.

Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H.

PLoS One. 2013;8(1):e53916. doi: 10.1371/journal.pone.0053916. Review.

11.

Metabolic syndrome, obesity, and gastrointestinal cancer.

Fujihara S, Mori H, Kobara H, Nishiyama N, Kobayashi M, Oryu M, Masaki T.

Gastroenterol Res Pract. 2012;2012:483623. doi: 10.1155/2012/483623.

12.

Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.

Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D.

Diabetes Care. 2012 Nov;35(11):2402-11. doi: 10.2337/dc12-0336. Review.

13.

The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.

Jinjuvadia R, Lohia P, Jinjuvadia C, Montoya S, Liangpunsakul S.

J Clin Gastroenterol. 2013 Jan;47(1):33-44. doi: 10.1097/MCG.0b013e3182688c15. Review.

14.

Diabetes but not insulin is associated with higher colon cancer mortality.

Tseng CH.

World J Gastroenterol. 2012 Aug 21;18(31):4182-90. doi: 10.3748/wjg.v18.i31.4182.

15.

Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?

Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA.

Am J Gastroenterol. 2011 Nov;106(11):1911-21; quiz 1922. doi: 10.1038/ajg.2011.301. Review.

16.

Site-specific risk factors for colorectal cancer in a Korean population.

Shin A, Joo J, Bak J, Yang HR, Kim J, Park S, Nam BH.

PLoS One. 2011;6(8):e23196. doi: 10.1371/journal.pone.0023196.

17.

Visceral adiposity, insulin resistance and cancer risk.

Donohoe CL, Doyle SL, Reynolds JV.

Diabetol Metab Syndr. 2011 Jun 22;3:12. doi: 10.1186/1758-5996-3-12.

18.

Metabolic syndrome and risk of death from cancers of the digestive system.

Matthews CE, Sui X, LaMonte MJ, Adams SA, Hébert JR, Blair SN.

Metabolism. 2010 Aug;59(8):1231-9. doi: 10.1016/j.metabol.2009.11.019.

19.

Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Godsland IF.

Clin Sci (Lond). 2009 Nov 23;118(5):315-32. doi: 10.1042/CS20090399. Review.

20.

Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.

Tsilidis KK, Brancati FL, Pollak MN, Rifai N, Clipp SL, Hoffman-Bolton J, Helzlsouer KJ, Platz EA.

Cancer Causes Control. 2010 Jan;21(1):1-10. doi: 10.1007/s10552-009-9428-6.

Items per page

Supplemental Content

Support Center